Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Polycystic Ovary Syndrome × mazdutide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

cetrorelix 2 Metformin 2 Chorionic Gonadotropin 2 mazdutide 1 drospirenone and ethinyl estradiol combination 1 Vitamin D 1 Triptorelin Pamoate 1 Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1 Sitagliptin Phosphate 1 Secretome 1 Rehydration Solutions 1 Menotropins 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Gonadotropins 1 Glucagon-Like Peptide-1 Receptor 1 Folic Acid 1 Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06519656 2024-10-24

Efficacy of Mazdutide for Treating PCOS

Shanghai Zhongshan Hospital

Phase 1/2 Recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡